+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Medical Exoskeleton Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 187 Pages
  • November 2025
  • Region: Global
  • 360iResearch™
  • ID: 5533178
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Medical exoskeletons are driving a pivotal transformation in healthcare by enabling advanced mobility and streamlined rehabilitation for diverse patient populations. As expectations shift toward technology-enabled care models, senior decision-makers need targeted, strategic insights to maintain resilience and optimize outcomes in an increasingly digital medical landscape.

Market Snapshot: Medical Exoskeleton Market Growth and Outlook

The global medical exoskeleton market experienced significant growth from 2024 to 2025, rising from USD 1.66 billion to USD 1.87 billion. Looking forward, the industry is expected to achieve a total value of USD 4.46 billion by 2032, with a compound annual growth rate of 13.11%. Growth is underpinned by increased demand for enhanced rehabilitation and improved clinical mobility, accelerated by technological advances in sensors and adaptive controls. The market also benefits from forward-looking regulations and the adoption of integrated care models. These trends prompt healthcare providers and industry leaders to revisit procurement strategies, develop new partnerships, and integrate digital solutions into standard workflows.

Scope & Segmentation: Strategic Perspectives for Leaders

This report offers actionable intelligence to help healthcare leadership prioritize investments in medical exoskeleton technology and implementation across multiple care settings. Segment-level analysis enables effective resource allocation and informed strategic planning for organizations aiming to innovate care delivery and patient services.

  • Component: Focuses on the operational reliability and integration capabilities of key exoskeleton hardware and software elements such as actuators, sensors, and control platforms. These enable alignment with evolving clinical and technical requirements.
  • Type: Assesses passive and powered exoskeleton solutions by highlighting their impact on patient recovery pathways, therapy conversion, and customization potential based on care needs.
  • Technology: Evaluates electric, hydraulic, mechanical, and pneumatic systems for compatibility with a variety of rehabilitation objectives and facility environments.
  • Functionality: Reviews full-body, upper-body, and lower-body rehabilitation capabilities to support differentiated therapy and precise patient engagement.
  • Structure: Compares rigid and soft exoskeleton mechanisms, emphasizing ergonomic design features that enhance patient comfort in clinical and home settings.
  • Mode of Operation: Analyzes autonomous, semi-autonomous, and manual systems to inform workforce development and optimize the integration of technology in clinical routines.
  • Application: Identifies use cases such as elderly mobility enhancement, disability management, and advanced diagnostics, supporting patient-centric and personalized rehabilitation programs.
  • End-Use: Surveys exoskeleton adoption in hospitals, long-term care, home rehabilitation, defense, research, and fitness, offering insight on operational adaptability and sector trends.
  • Regional Coverage: Provides context for decision-makers on regional policy changes, local investment opportunities, and market entry requirements across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific.
  • Companies Analyzed: Benchmarks competitive positioning and partnership strengths of major organizations including B-Temia, Hyundai Motor, Lockheed Martin, Myomo, and ReWalk Robotics for strategic planning and peer comparison.

Medical Exoskeleton Market: Key Takeaways

  • AI-enabled control systems support personalized rehabilitation by enabling adaptable responses to a wide range of patient needs and clinical requirements.
  • Real-time data integration and use of advanced sensors enhance workflow productivity and boost the efficacy of continuous patient monitoring protocols.
  • Regional variations in reimbursement policies and regulatory frameworks demand locally tailored market entry and investment strategies.
  • Alliance-building among developers, clinicians, and researchers drives market readiness and the continual improvement of exoskeleton system utility.
  • Modular design innovations reduce deployment time and facilitate integration with existing digital health systems, lowering operational friction for care teams.
  • Long-term uptake relies on balancing new technical capabilities with evolving patient expectations and clinical care standards, ensuring ongoing value for all stakeholders.

Tariff Impact on Supply Chain Dynamics

Recently introduced tariffs on core medical exoskeleton components have pushed manufacturers to diversify their sourcing approaches, building greater supply chain agility. To address potential disruptions, healthcare organizations are refining inventory management and logistics processes. Continuous regulatory tracking is essential to maintain compliance and availability for critical medical devices.

Methodology & Data Sources

This report draws on peer-reviewed research, regulatory analysis, industry financial data, and expert interviews. Relying on multiple sources ensures a well-rounded foundation for executives evaluating medical exoskeleton procurement or adoption strategies.

Why This Report Matters for Senior Decision-Makers

  • Enables informed capital and resource allocation in dynamic, regulated healthcare and B2B environments.
  • Helps decision-makers proactively manage risk, streamline market entry, and fine-tune strategies to match ongoing sector changes.
  • Equips executive leadership with actionable, analytics-driven recommendations for effective technology partnership and procurement choices.

Conclusion

Ongoing advancements in medical exoskeleton technology are shaping new standards in rehabilitation and patient mobility. Achieving sustainable gains will depend on flexible leadership, regulatory insight, and coordinated innovation among clinical and technology stakeholders.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of artificial intelligence algorithms for adaptive exoskeleton assistance in rehabilitation programs
5.2. Adoption of lightweight composite materials and modular designs to enhance patient comfort and mobility in exoskeleton devices
5.3. Strategic partnerships between medical exoskeleton startups and major healthcare providers for clinical trial expansion
5.4. Emergence of tele-rehabilitation platforms with remote monitoring capabilities in medical exoskeleton treatments
5.5. Advancements in battery technology and wireless control systems to extend exoskeleton operational duration in clinical settings
5.6. Regulatory approvals and updated reimbursement frameworks driving increased accessibility of medical exoskeleton therapies
5.7. Integration of virtual reality environments with exoskeleton systems for immersive neurorehabilitation and patient engagement
5.8. Customization of exoskeleton design through 3D scanning and additive manufacturing accelerating patient-specific fit
5.9. Expansion of tele-rehabilitation platforms incorporating remote-controlled exoskeleton training for stroke patients
5.10. Surge in soft robotic exosuit adoption for elderly mobility support in home healthcare settings
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Medical Exoskeleton Market, by Component
8.1. Hardware
8.1.1. Actuators
8.1.2. Microcontrollers
8.1.3. Sensors
8.2. Software
8.2.1. Control Software
8.2.2. Monitoring Software
9. Medical Exoskeleton Market, by Type
9.1. Passive Exoskeletons
9.2. Powered Exoskeletons
10. Medical Exoskeleton Market, by Technology
10.1. Electric
10.2. Hydraulic
10.3. Mechanical
10.4. Pneumatic
11. Medical Exoskeleton Market, by Functionality
11.1. Full Body Exoskeletons
11.2. Lower Body Exoskeletons
11.3. Upper Body Exoskeletons
12. Medical Exoskeleton Market, by Structure
12.1. Rigid Exoskeletons
12.2. Soft Exoskeletons
13. Medical Exoskeleton Market, by Mode of Operation
13.1. Autonomous Exoskeletons
13.2. Manual Controlled
13.3. Semi Autonomous/Assisted
14. Medical Exoskeleton Market, by Application
14.1. Assistive Devices for Mobility
14.1.1. Disabled Patients
14.1.2. Elderly Assistance
14.2. Diagnostic Support
14.3. Rehabilitation
14.4. Surgical Assistance
14.5. Therapeutic Use
14.5.1. Orthopedic Recovery
14.5.2. Physical Therapy
15. Medical Exoskeleton Market, by End-Use
15.1. Elderly Care Facilities
15.2. Homecare Settings
15.3. Military & Defense
15.4. Research Institutions & Universities
15.5. Sports & Fitness
16. Medical Exoskeleton Market, by Region
16.1. Americas
16.1.1. North America
16.1.2. Latin America
16.2. Europe, Middle East & Africa
16.2.1. Europe
16.2.2. Middle East
16.2.3. Africa
16.3. Asia-Pacific
17. Medical Exoskeleton Market, by Group
17.1. ASEAN
17.2. GCC
17.3. European Union
17.4. BRICS
17.5. G7
17.6. NATO
18. Medical Exoskeleton Market, by Country
18.1. United States
18.2. Canada
18.3. Mexico
18.4. Brazil
18.5. United Kingdom
18.6. Germany
18.7. France
18.8. Russia
18.9. Italy
18.10. Spain
18.11. China
18.12. India
18.13. Japan
18.14. Australia
18.15. South Korea
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. B-Temia Inc.
19.3.2. Comau S.p.A.
19.3.3. Cyberdyne Inc.
19.3.4. Ekso Bionics Holdings Inc.
19.3.5. ExoAtlet, LLC
19.3.6. Focal Meditech BV
19.3.7. Honda Motor Co. Ltd.
19.3.8. Hyundai Motor Company
19.3.9. Levitate Technologies, Inc.
19.3.10. Lockheed Martin Corporation
19.3.11. Mitsubishi Heavy Industries, Ltd.
19.3.12. Myomo, Inc.
19.3.13. Ottobock SE & Co. KGaA
19.3.14. P&S Mechanics Co., Ltd.
19.3.15. Panasonic Holdings Corporation
19.3.16. Parker Hannifin Corporation
19.3.17. ReWalk Robotics Ltd.
19.3.18. Rex Bionics Plc
19.3.19. Roam Robotics
19.3.20. Toyota Motor Corporation
19.3.21. Trexo Robotics, Inc.
19.3.22. Wandercraft S.A.S.
19.3.23. Yaskawa Electric Corporation
List of Tables
List of Figures

Companies Mentioned

The companies profiled in this Medical Exoskeleton market report include:
  • B-Temia Inc.
  • Comau S.p.A.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings Inc.
  • ExoAtlet, LLC
  • Focal Meditech BV
  • Honda Motor Co. Ltd.
  • Hyundai Motor Company
  • Levitate Technologies, Inc.
  • Lockheed Martin Corporation
  • Mitsubishi Heavy Industries, Ltd.
  • Myomo, Inc.
  • Ottobock SE & Co. KGaA
  • P&S Mechanics Co., Ltd.
  • Panasonic Holdings Corporation
  • Parker Hannifin Corporation
  • ReWalk Robotics Ltd.
  • Rex Bionics PLC
  • Roam Robotics
  • Toyota Motor Corporation
  • Trexo Robotics, Inc.
  • Wandercraft S.A.S.
  • Yaskawa Electric Corporation

Table Information